Personalized Approach to Olfactory Neuroblastoma Care
David K Lerner1, James N Palmer1
1Department of Otolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA.
Journal of Personalized Medicine
|April 27, 2024
Summary
Olfactory neuroblastoma (ONB), a rare cancer, requires prompt diagnosis via imaging and endoscopy. Standard treatment involves surgical resection, with adjuvant therapies and surveillance crucial for managing metastasis and recurrence.
Area of Science:
- Oncology
- Otorhinolaryngology
- Neuroscience
Background:
- Olfactory neuroblastoma (ONB) is a rare neuroendocrine tumor originating in the olfactory epithelium.
- ONB often presents with vague sinonasal symptoms, delaying diagnosis.
Purpose of the Study:
- To outline the diagnostic and management strategies for olfactory neuroblastoma.
- To highlight the importance of multidisciplinary care in treating this uncommon malignancy.
Main Methods:
- Diagnosis involves physical examination, nasal endoscopy, CT, and MRI.
- Standard treatment includes endoscopic resection, potentially with craniotomy.
- Management of regional metastasis involves neck dissection or radiation therapy.
Main Results:
- Early diagnosis and complete surgical resection are key to favorable outcomes.
- Adjuvant radiotherapy is recommended for high-grade or advanced-stage tumors.
- Systemic therapies and immunotherapies are under investigation for advanced or recurrent disease.
Conclusions:
- ONB management requires a comprehensive approach, including surgery, adjuvant therapies, and vigilant surveillance.
- Ongoing research into systemic and targeted therapies holds promise for improving treatment of recurrent or metastatic ONB.
